SEC Form 5 · accession 0001053369-15-000013
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas Plassche
Officer — Executive VP of Operations
Period of report
Mar 31, 2015
Accepted (ET)
Apr 9, 2015 · 1:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 25, 2014 | A | 85,530 | $0.1137 | A | 85,530 | D | |
| Common StockF2 | Feb 27, 2015 | A | 73,094 | $0.342 | A | 158,624 | D | |
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Form 3 should have been filed on or about August 12, 2013.
- F2Represents the amount owned following the respective dates of the transactions and as of the end of the respective fiscal years.
- F3Distribution from the Issuer.